These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12886553)

  • 1. [Who is to be treated with statin?].
    Heebøll-Nielsen NC
    Ugeskr Laeger; 2003 Jun; 165(26):2669-70; author reply 2670. PubMed ID: 12886553
    [No Abstract]   [Full Text] [Related]  

  • 2. [DSAM's clinical guidelines for prevention of ischemic heart disease 2007].
    Ibsen H
    Ugeskr Laeger; 2007 May; 169(21):2039; author reply 2041. PubMed ID: 17571319
    [No Abstract]   [Full Text] [Related]  

  • 3. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 4. U.S. statin guidelines: expensive but not necessarily effective.
    Barry HC; Hoffman JR
    Am Fam Physician; 2007 May; 75(10):1453-4, 1456. PubMed ID: 17555139
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical guidelines and prevention of ischemic heart disease in family practice].
    Lauritzen T; Christensen B
    Ugeskr Laeger; 1998 Dec; 160(50):7239. PubMed ID: 9859719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Criteria concerning antilipemic agent administration].
    Thomsen E
    Ugeskr Laeger; 2000 Oct; 162(44):5962. PubMed ID: 11094570
    [No Abstract]   [Full Text] [Related]  

  • 7. [To the Heart Society and the National Board of Health and Welfare].
    Skovenborg E
    Ugeskr Laeger; 1999 Oct; 161(40):5554-5. PubMed ID: 10553372
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Medical Products Agency's new guidelines on complements to medical treatment of hypercholesterolemia].
    Nielsen PE; McNair A; Rasmussen S; Pedersen FH
    Ugeskr Laeger; 1998 Aug; 160(32):4665-7. PubMed ID: 9719755
    [No Abstract]   [Full Text] [Related]  

  • 9. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of HDL cholesterol increase for the risk reduction. Methods of intervention. recommendations of experts].
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II5-12. PubMed ID: 19813328
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of ischemic heart disease--evidence-based].
    Heebøll-Nielsen NC
    Ugeskr Laeger; 2000 Sep; 162(37):4941-3. PubMed ID: 11002746
    [No Abstract]   [Full Text] [Related]  

  • 13. [LIMA-register: rationale, aims and design].
    Bestehorn K; Schäfer J; Gitt AK; Jannowitz C; Karmann B; Sonntag F; Weizel A
    MMW Fortschr Med; 2008 Sep; 150 Suppl 3():135-41. PubMed ID: 19025216
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 15. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 17. [Even at LDL cholesterol 100mg/dl. "Every coronary disease patient has to receive a statin"].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963997
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis.
    Merla R; Reddy NK; Wang FW; Uretsky BF; Barbagelata A; Birnbaum Y
    Am J Cardiol; 2007 Sep; 100(5):770-6. PubMed ID: 17719318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
    Maron DJ
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):18-9. PubMed ID: 16265253
    [No Abstract]   [Full Text] [Related]  

  • 20. [Practice guidelines for physicians and related economic considerations].
    Simoons ML; Casparie AF
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):874-5. PubMed ID: 10347660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.